Bio-Rad Laboratories Inc

NYSE:BIO USA Medical Devices
Market Cap
$5.91 Billion
Market Cap Rank
#2539 Global
#1779 in USA
Share Price
$269.48
Change (1 day)
+3.15%
52-Week Range
$216.56 - $339.75
All Time High
$825.77
About

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more

Bio-Rad Laboratories Inc - Asset Resilience Ratio

Latest as of December 2025: 14.57%

Bio-Rad Laboratories Inc (BIO) has an Asset Resilience Ratio of 14.57% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$1.54 Billion
Cash + Short-term Investments
Total Assets
$10.58 Billion
All company assets
Resilience Assessment
Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2003–2025)

This chart shows how Bio-Rad Laboratories Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Bio-Rad Laboratories Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $529.80 Million 5.01%
Short-term Investments $1.01 Billion 9.56%
Total Liquid Assets $1.54 Billion 14.57%

Asset Resilience Insights

  • Moderate Liquidity: Bio-Rad Laboratories Inc has 14.57% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Bio-Rad Laboratories Inc Industry Peers by Asset Resilience Ratio

Compare Bio-Rad Laboratories Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Bio-Rad Laboratories Inc (2003–2025)

The table below shows the annual Asset Resilience Ratio data for Bio-Rad Laboratories Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 14.57% $1.54 Billion $10.58 Billion -3.21pp
2024-12-31 17.78% $1.66 Billion $9.36 Billion +4.71pp
2023-12-31 13.07% $1.61 Billion $12.30 Billion -0.20pp
2022-12-31 13.26% $1.79 Billion $13.50 Billion +8.38pp
2021-12-31 4.89% $869.92 Million $17.80 Billion -2.75pp
2020-12-31 7.64% $991.12 Million $12.97 Billion -6.28pp
2019-12-31 13.92% $1.11 Billion $8.01 Billion -1.14pp
2018-12-31 15.06% $844.80 Million $5.61 Billion -2.61pp
2017-12-31 17.67% $754.98 Million $4.27 Billion -4.13pp
2016-12-31 21.80% $839.44 Million $3.85 Billion +12.94pp
2015-12-31 8.86% $328.72 Million $3.71 Billion +0.35pp
2014-12-31 8.51% $284.38 Million $3.34 Billion +0.33pp
2013-12-31 8.18% $277.37 Million $3.39 Billion -5.11pp
2012-12-31 13.29% $457.69 Million $3.44 Billion +5.58pp
2011-12-31 7.71% $238.88 Million $3.10 Billion +3.84pp
2010-12-31 3.87% $118.64 Million $3.06 Billion +0.13pp
2009-12-31 3.74% $94.88 Million $2.54 Billion +1.83pp
2008-12-31 1.91% $38.95 Million $2.04 Billion -1.23pp
2007-12-31 3.14% $61.98 Million $1.97 Billion -13.43pp
2006-12-31 16.57% $264.47 Million $1.60 Billion +8.41pp
2005-12-31 8.16% $116.34 Million $1.43 Billion -3.94pp
2004-12-31 12.10% $165.90 Million $1.37 Billion +3.71pp
2003-12-31 8.39% $83.25 Million $992.60 Million --
pp = percentage points